No Pharmacokinetic Drug–Drug Interaction Between Prasugrel and Vorapaxar Following Multiple‐Dose Administration in Healthy Volunteers

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|7|2|143-150

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.7, Iss.2, 2018-02, pp. : 143-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lack of Pharmacokinetic Drug-Drug Interaction between Orlistat and Cerivastatin

By Mück W.   Adelmann H-G.   Ruf T.   Unger S.   Voith B.  

Clinical Drug Investigation, Vol. 19, Iss. 1, 2000-01 ,pp. : 71-73

Adis International

Access to resources Recommend Favorite

Phase Ib Single- and Multiple-Dose Pharmacokinetic Study of Oral NV-52 in Healthy Volunteers

By Howes Laurence G.  

Drugs in R&D, Vol. 9, Iss. 3, 2008-01 ,pp. : 159-166

Adis International

Access to resources Recommend Favorite

What is the true risk of a pharmacokinetic drug–drug interaction?

By Fuhr Uwe  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 10, 2007-10 ,pp. : 897-899

Springer Publishing Company

Access to resources Recommend Favorite

Randomized Open-Label Drug-Drug Interaction Trial of Dextromethorphan/Quinidine and Paroxetine in Healthy Volunteers

By Schoedel Kerri A.  

Clinical Drug Investigation, Vol. 32, Iss. 3, 2012-03 ,pp. : 157-169

Adis International

Access to resources Recommend Favorite

Single‐ and multiple‐dose pharmacokinetics of tofacitinib in healthy Chinese volunteers

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 5, 2015-09 ,pp. : 395-399

John Wiley & Sons Inc

Access to resources Recommend Favorite